Effects of Major Ozone Autohemotherapy on Physical Functionality and Quality of Life in Fibromyalgia Syndrome

Type: Prospective Cross-sectional Study

Author:  Gülçin Gazioğlu Türkyılmaz, Şebnem Rumeli, Mesut Bakır

Summary:

 Significant improvement in FIQ and SF-36 scores was observed in all periods compared to the previous period (P < .05). Between two consecutive measurements the most prominent improvements in both FIQ scores (P < .001) and SF-36 scores was observed between baseline and the PT period (P < .001). Significant improvement also occurred in all SF36 subscale scores between PT and PT3 (P ≤ .02).

The study was the first to demonstrate the efficacy of MAH for fibromyalgia patients as found using FIQ and SF-36 questionnaires repeated at certain intervals. The study found that MAH provided improvements in quality of life and general health status for FMS patients.

Link to paper

 

Many of our customers use ozone therapy at home as a complementary part of their wellness routine, alongside the care of their health practitioner.

×